Varonis Systems, Inc. (VRNS)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-10-30
$48.85+0.06%
Close 2026-10-30 · 1-day change
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-10-30
Research Workspace
Put VRNS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Systems Software: fringe margins under pressure (2q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 16% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 44% in its worst 12-month stretch.
View RiskVRNS’s core bet now centers on its reported Proofpoint acquisition, not standalone growth alone. Revenue grew 18% year over year in Q2 FY2026, when non-GAAP earnings beat. The shares trade at 8× sales versus a 4× peer median and 8× historical multiple. Our expectations view says the price reflects less growth than we forecast. A 25% next-quarter miss probability and the peer premium are specific risks. The thesis remains intact, though recent financial performance is weak relative to its industry cohort. Peer multiples imply a price about 20% below where it trades; this read is provisional.
Trailing returns as of 2026-10-30. VRNS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 37 analysts currently covering VRNS (as of Oct 2026).
Based on 13 Wall Street analysts offering 12-month price targets for VRNS in the last 4 months.
Continue this research
Compare VRNS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| VRNS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Systems Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put VRNS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Reported $6.3 billion cash acquisition would materially change Varonis’s standalone investment thesis.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $48.85
The last 12 months of price, then the range of analyst 12-month targets from today’s $48.85.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Stock reaction reflects reported acquisition premium, though it repeats the same deal.
New tool supports growth in SaaS ARR and revenue.
Advances: Achieve SaaS ARR growth of 28% to 33% in 2026
SaaS shift aligns with growth objectives.
Advances: Achieve SaaS ARR growth of 28% to 33% in 2026
Strong SaaS growth supports ARR growth objective.
Advances: Achieve revenue growth of 18% to 19% in 2026
Positive earnings call indicates revenue growth potential.
Threatens: Achieve revenue growth of 17% to 18%
Stock drop despite revenue beat raises concerns about growth.
Threatens: Achieve revenue growth of 17% to 18%
Revenue beat not translating to stock performance indicates potential issues.